MarketPulse
B

$BCDA

3 articles found
2 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Biocardia, Inc.

BioCardia Gets FDA Nod on Dual Pathways for Helix Catheter System

BioCardia secured FDA alignment on two regulatory routes for its Helix transendocardial delivery catheter, with the agency backing simultaneous approval with CardiAMP cell therapy.
BCDAcell therapymedical device
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioCardia to Unveil 2025 Results, Corporate Strategy on March 24 Call

BioCardia scheduled conference call for March 24, 2026 to report full-year 2025 financial results and provide corporate update.
BCDAfinancial resultsconference call
GlobeNewswire Inc.GlobeNewswire Inc.··Biocardia, Inc.

BioCardia's Helix Catheter Clears FDA Pre-Submission Milestone

BioCardia wins FDA acceptance of pre-submission package for Helix transendocardial delivery catheter, advancing minimally invasive cardiac therapy platform.
BCDAFDA approvalminimally invasive